OXANDRIN Side Effects

5475663-2 | Confusional State, Delirium, Gait Disturbance, Urinary Incontinence
on Sep 20, 2007 Female patient from UNITED STATES , 82 years of age, weighting 95.00 lb, was diagnosed with weight decreased and was treated with Oxandrin (View Usage). Patient experienced the following unwanted or unexpected effects: confusional state, delirium, gait disturbance, urinary incontinence (What is urinary incontinence?). Oxandrin dosage: . During the same period patient was treated with CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), ETHAMBUTOL HCL (View Ethambutol Hcl Review and Ethambutol Hcl Label ), ROBITUSSIN (View Robitussin Review and Robitussin Label ). Patient was hospitalized.

5399935-5 | Disease Progression
Patient was taking Oxandrin (View Usage). Patient had the following side effects: disease progression on Jul 26, 2007 from UNITED STATES Additional patient health information: Male patient , weighting 119.5 lb, was diagnosed with weight decreased and. Oxandrin dosage: 10 Mg Bid Po.

5399926-4 | Ascites, Disease Progression, Transient Ischaemic Attack
Adverse event was reported on Jul 26, 2007 by a Male patient taking Oxandrin (View Usage) (Dosage: 10mg Bid Po) was diagnosed with weight decreased and. Location: UNITED STATES , weighting 119.5 lb, After Oxandrin was administered, patient had the following side effects: ascites, disease progression, transient ischaemic attack. During the same period patient was treated with NIFEREX (View Niferex Review and Niferex Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), PHENERGAN HCL (View Phenergan Hcl Review and Phenergan Hcl Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), VITAMIN CAP (View Vitamin Cap Review and Vitamin Cap Label ), REGLAN (View Reglan Review and Reglan Label ), LASIX (View Lasix Review and Lasix Label ), IMODIUM (View Imodium Review and Imodium Label ). Patient was hospitalized.

5399923-9 | Anaemia, Ascites, Disease Progression, Gastric Cancer
on Jul 26, 2007 Male patient from UNITED STATES , weighting 119.5 lb, was diagnosed with weight decreased and was treated with Oxandrin (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, ascites, disease progression, gastric cancer. Oxandrin dosage: 10mg Bid Po. During the same period patient was treated with NIFEREX (View Niferex Review and Niferex Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), PHENERGAN HCL (View Phenergan Hcl Review and Phenergan Hcl Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), VITAMIN CAP (View Vitamin Cap Review and Vitamin Cap Label ), REGLAN (View Reglan Review and Reglan Label ), LASIX (View Lasix Review and Lasix Label ), IMODIUM (View Imodium Review and Imodium Label ). Patient was hospitalized.


5281473-1 | Anaemia, Blood Creatinine, Dehydration, Hyperkalaemia, Oedema Peripheral, Oral Intake Reduced, Renal Failure, Urine Output Decreased
on Mar 23, 2007 Male patient from UNITED STATES , 78 years of age, weighting 176.0 lb, was diagnosed with decreased appetite and was treated with Oxandrin (View Usage). Patient had the following side effects: anaemia, blood creatinine, dehydration, hyperkalaemia, oedema peripheral, oral intake reduced, renal failure, urine output decreased. Oxandrin dosage: 10 Mg Po Bid. Patient was hospitalized.

5253919-6 |
Patient was taking Oxandrin (View Usage). on Feb 28, 2007 from UNITED STATES Additional patient health information: Female patient , weighting 105.0 lb, was diagnosed with weight decreased and. Oxandrin dosage: 10mg Po Bid. During the same period patient was treated with OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ), LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ), ARANESP (View Aranesp Review and Aranesp Label ).

5221714-X |
Adverse event was reported on Jan 26, 2007 by a Female patient taking Oxandrin (View Usage) (Dosage: 10 Mg Po Bid) was diagnosed with weight control (What is weight control?) and. Location: UNITED STATES , weighting 105.0 lb, . During the same period patient was treated with OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ), LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ), ARANESP (View Aranesp Review and Aranesp Label ).

5145637-X | Cough, Epistaxis, Fluid Overload, Oedema Peripheral, Pain In Extremity, Weight Increased
on Oct 20, 2006 Female patient from UNITED STATES , 58 years of age, weighting 201.0 lb, was diagnosed with decreased appetite and was treated with Oxandrin (View Usage). Patient had the following side effects: cough, epistaxis, fluid overload, oedema peripheral, pain in extremity, weight increased. Oxandrin dosage: 2.5 Mg; Bid; Po. During the same period patient was treated with POTASSIUM ACETATE (View Potassium Acetate Review and Potassium Acetate Label ), MAGNESIUM (View Magnesium Review and Magnesium Label ), ATIVAN (View Ativan Review and Ativan Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.

5143199-4 | Asthenia, Constipation, Fatigue, Nausea
on Oct 31, 2006 Male patient from UNITED STATES , 60 years of age, weighting 203.0 lb, was diagnosed with weight decreased and was treated with Oxandrin (View Usage). After Oxandrin was administered, patient had the following side effects: asthenia, constipation (What is constipation?), fatigue, nausea (What is nausea?). Oxandrin dosage: 10mg Bid Po. During the same period patient was treated with CIALIS (View Cialis Review and Cialis Label ), REMERON (View Remeron Review and Remeron Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PROTONIX (View Protonix Review and Protonix Label ), MOROPHINE (View Morophine Review and Morophine Label ), REQUIP (View Requip Review and Requip Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ). Patient was hospitalized.

5140212-5 | Disease Progression, Hypoxia, Pneumonia, Pneumonitis, Pulmonary Oedema, Respiratory Failure
Patient was taking Oxandrin (View Usage). Patient experienced the following unwanted or unexpected effects: disease progression, hypoxia, pneumonia (What is pneumonia?), pneumonitis, pulmonary oedema, respiratory failure on Oct 26, 2006 from UNITED STATES Additional patient health information: Male patient , 54 years of age, weighting 186.0 lb, was diagnosed with weight decreased and. Oxandrin dosage: 10mg Bid Po. During the same period patient was treated with HYDROXYZINE (View Hydroxyzine Review and Hydroxyzine Label ), CELEBREX (View Celebrex Review and Celebrex Label ), FENTANYL TRANSDERMAL SYSTEM (View Fentanyl Transdermal System Review and Fentanyl Transdermal System Label ), RESTORIL (View Restoril Review and Restoril Label ), SINGULAIR (View Singulair Review and Singulair Label ), ADVAIR DISKUS 250/50 (View Advair Diskus 250/50 Review and Advair Diskus 250/50 Label ), NORVASC (View Norvasc Review and Norvasc Label ), PROZAC (View Prozac Review and Prozac Label ). Patient was hospitalized.

5122530-X | Hypoxia
Adverse event was reported on Oct 04, 2006 by a Male patient taking Oxandrin (View Usage) (Dosage: 10mg Bid Po) was diagnosed with weight decreased and. Location: UNITED STATES , 54 years of age, weighting 186.0 lb, Patient had the following side effects: hypoxia. During the same period patient was treated with HYDROXYZINE (View Hydroxyzine Review and Hydroxyzine Label ), SINGULAIR (View Singulair Review and Singulair Label ), PROZAC (View Prozac Review and Prozac Label ), CELEBREX (View Celebrex Review and Celebrex Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), FLONASE (View Flonase Review and Flonase Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ). Patient was hospitalized.

5122527-X | No Adverse Effect
on Oct 04, 2006 Male patient from UNITED STATES , weighting 179.0 lb, was diagnosed with weight decreased and was treated with Oxandrin (View Usage). After Oxandrin was administered, patient had the following side effects: no adverse effect. Oxandrin dosage: 10 Mg Po Bid. During the same period patient was treated with NIASPAN (View Niaspan Review and Niaspan Label ), DOXAZOSIN (View Doxazosin Review and Doxazosin Label ), ALTACE (View Altace Review and Altace Label ). Patient was hospitalized.

5104680-7 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Bilirubin Increased, Dyspnoea, Nausea, Pneumonia
on Sep 12, 2006 Male patient from UNITED STATES , 59 years of age, weighting 178.0 lb, was diagnosed with weight decreased and was treated with Oxandrin (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, dyspnoea, nausea (What is nausea?), pneumonia (What is pneumonia?). Oxandrin dosage: 10 Mg Bid Po. During the same period patient was treated with VICODIN (View Vicodin Review and Vicodin Label ), BUTALBITAL (View Butalbital Review and Butalbital Label ), WELLBUTRIN SR (View Wellbutrin Sr Review and Wellbutrin Sr Label ), FLOMAX (View Flomax Review and Flomax Label ), MORPHINE (View Morphine Review and Morphine Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), LIPITOR (View Lipitor Review and Lipitor Label ), PRILOSEC (View Prilosec Review and Prilosec Label ). Patient was hospitalized.

5096894-X | Blood Pressure Decreased, Dyspnoea, Fall, Head Injury, Hyperhidrosis, Inappropriate Antidiuretic Hormone Secretion, Loss Of Consciousness
Patient was taking Oxandrin (View Usage). Patient had the following side effects: blood pressure decreased, dyspnoea, fall (What is fall?), head injury, hyperhidrosis, inappropriate antidiuretic hormone secretion, loss of consciousness on Sep 01, 2006 from UNITED STATES Additional patient health information: Female patient , 81 years of age, weighting 146.0 lb, was diagnosed with weight decreased and. Oxandrin dosage: 10 Mg Bid Po.

5062800-7 | Renal Failure Acute
Adverse event was reported on Jul 25, 2006 by a Male patient taking Oxandrin (View Usage) (Dosage: 10mg Po Bid) was diagnosed with weight decreased and. Location: UNITED STATES , weighting 244.0 lb, After Oxandrin was administered, patient had the following side effects: renal failure acute. During the same period patient was treated with OXYCONTIN (View Oxycontin Review and Oxycontin Label ), PERCOCET (View Percocet Review and Percocet Label ), DILAUDID (View Dilaudid Review and Dilaudid Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), ATENOLOL AND CHLORTHALIDONE (View Atenolol And Chlorthalidone Review and Atenolol And Chlorthalidone Label ), DARVOCET N 100 (View Darvocet-n 100 Review and Darvocet-n 100 Label ), VICODIN (View Vicodin Review and Vicodin Label ). Patient was hospitalized.

5062798-1 | Febrile Neutropenia
on Jul 25, 2006 Female patient from UNITED STATES , 81 years of age, weighting 128.0 lb, was diagnosed with weight decreased and was treated with Oxandrin (View Usage). Patient experienced the following unwanted or unexpected effects: febrile neutropenia. Oxandrin dosage: 10mg Po Bid. During the same period patient was treated with PROMETHAZINE (View Promethazine Review and Promethazine Label ), PLAVIX (View Plavix Review and Plavix Label ), DIOVAN HCT (View Diovan Hct Review and Diovan Hct Label ), ACTOS/MET (View Actos/met Review and Actos/met Label ), NEXIUM (View Nexium Review and Nexium Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), DETROL LA (View Detrol La Review and Detrol La Label ), XALATAN (View Xalatan Review and Xalatan Label ). Patient was hospitalized.

5041025-5 | Dyspnoea
on Jun 29, 2006 Male patient from UNITED STATES , 52 years of age, weighting 180.0 lb, was diagnosed with weight decreased and was treated with Oxandrin (View Usage). Patient had the following side effects: dyspnoea. Oxandrin dosage: 2 Tablets (10 Mg Each Bid Oral. During the same period patient was treated with MS CONTIN (View Ms Contin Review and Ms Contin Label ), DULCOLAX (View Dulcolax Review and Dulcolax Label ), SENOKOT (View Senokot Review and Senokot Label ). Patient was hospitalized.

5026598-0 | Haemoptysis
Patient was taking Oxandrin (View Usage). After Oxandrin was administered, patient had the following side effects: haemoptysis on Jun 13, 2006 from UNITED STATES Additional patient health information: Male patient , 67 years of age, weighting 236.0 lb, was diagnosed with weight decreased and. Oxandrin dosage: 10mg Bid Po. During the same period patient was treated with OXYCONTIN (View Oxycontin Review and Oxycontin Label ), PERCOCET (View Percocet Review and Percocet Label ), DILAUDID (View Dilaudid Review and Dilaudid Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), ATENOLOL AND CHLORTHALIDONE (View Atenolol And Chlorthalidone Review and Atenolol And Chlorthalidone Label ), DARVOCET N 100 (View Darvocet-n 100 Review and Darvocet-n 100 Label ), VICODIN (View Vicodin Review and Vicodin Label ), GEMZAR (View Gemzar Review and Gemzar Label ). Patient was hospitalized.

5011734-2 | Appetite Disorder, Balance Disorder, Confusional State, Delirium, Urinary Incontinence
Adverse event was reported on May 23, 2006 by a Female patient taking Oxandrin (View Usage) (Dosage: One Dose Daily Po) was diagnosed with weight decreased and. Location: UNITED STATES , 82 years of age, weighting 95.00 lb, Patient experienced the following unwanted or unexpected effects: appetite disorder, balance disorder, confusional state, delirium, urinary incontinence (What is urinary incontinence?). During the same period patient was treated with CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), ETHAMBUTOL (View Ethambutol Review and Ethambutol Label ), ROBITUSSIN WITH CODEINE (View Robitussin With Codeine Review and Robitussin With Codeine Label ). Patient was hospitalized.

4999811-3 | Anorexia, Dehydration, Dysphasia, Fatigue, Haemoglobin Decreased, Weight Decreased
on May 09, 2006 Female patient from UNITED STATES , weighting 103.0 lb, was diagnosed with weight decreased and was treated with Oxandrin (View Usage). Patient had the following side effects: anorexia, dehydration, dysphasia, fatigue, haemoglobin decreased, weight decreased. Oxandrin dosage: 10mg One Pill Twice A Day. Patient was hospitalized.

4907754-6 | Constipation, Convulsion, Dehydration, Nausea
on Feb 08, 2006 Male patient from UNITED STATES , 48 years of age, was diagnosed with lung neoplasm malignant, weight decreased and was treated with Oxandrin (View Usage). After Oxandrin was administered, patient had the following side effects: constipation (What is constipation?), convulsion, dehydration, nausea (What is nausea?). Oxandrin dosage: 10mg One Po Bid. Patient was hospitalized.

4882266-7 | Dehydration, Hypotension, Infection, Neutropenia
Patient was taking Oxandrin (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration, hypotension, infection (What is infection?), neutropenia on Jan 13, 2006 from UNITED STATES Additional patient health information: Female patient , 74 years of age, weighting 169.0 lb, was diagnosed with weight decreased and. Oxandrin dosage: 10 Mg Bid Po. During the same period patient was treated with COZAAR (View Cozaar Review and Cozaar Label ), CELEBREX (View Celebrex Review and Celebrex Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), TYLENOL (CAPLET) (View Tylenol (caplet) Review and Tylenol (caplet) Label ), VICODIN (View Vicodin Review and Vicodin Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), TAXOTERE (View Taxotere Review and Taxotere Label ). Patient was hospitalized.

4854287-1 | Cerebrovascular Accident, Infection, Treatment Noncompliance, Upper Gastrointestinal Haemorrhage
Adverse event was reported on Dec 13, 2005 by a Female patient taking Oxandrin (View Usage) (Dosage: 10 Mg (bid Po)) was diagnosed with weight decreased and. Location: UNITED STATES , weighting 94.00 lb, Patient had the following side effects: cerebrovascular accident, infection (What is infection?), treatment noncompliance, upper gastrointestinal haemorrhage.

4851966-7 | Balance Disorder, Dizziness
on Nov 28, 2005 Female patient from UNITED STATES , 80 years of age, weighting 58.00 lb, was diagnosed with decreased appetite and was treated with Oxandrin (View Usage). After Oxandrin was administered, patient had the following side effects: balance disorder, dizziness (What is dizziness?). Oxandrin dosage: 10 Mg; Qd; Unk. During the same period patient was treated with SPIRIVA (View Spiriva Review and Spiriva Label ), AVELOX (View Avelox Review and Avelox Label ), BIAXIN (View Biaxin Review and Biaxin Label ), ADVAIR DISKUS 250/50 (View Advair Diskus 250/50 Review and Advair Diskus 250/50 Label ), ETHAMBUTOL (View Ethambutol Review and Ethambutol Label ), VITAMINS NOS (View Vitamins Nos Review and Vitamins Nos Label ), IRON (View Iron Review and Iron Label ), OXYGEN (View Oxygen Review and Oxygen Label ).

4819586-8 | Diarrhoea
on Nov 02, 2005 Female patient from UNITED STATES , 75 years of age, weighting 218.3 lb, was diagnosed with weight decreased and was treated with Oxandrin (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea. Oxandrin dosage: 10 Mg Bid Po. During the same period patient was treated with ARANESP (View Aranesp Review and Aranesp Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), LEUKINE (View Leukine Review and Leukine Label ), KYTRIL (View Kytril Review and Kytril Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), MAXZIDE (View Maxzide Review and Maxzide Label ), BENTYL (View Bentyl Review and Bentyl Label ), PHENERGAN (View Phenergan Review and Phenergan Label ). Patient was hospitalized.

4755415-9 | Dehydration, Nausea, Pain, Procedural Complication
Patient was taking Oxandrin (View Usage). Patient had the following side effects: dehydration, nausea (What is nausea?), pain (What is pain?), procedural complication on Aug 26, 2005 from UNITED STATES Additional patient health information: Male patient , weighting 130.0 lb, was diagnosed with weight decreased and. Oxandrin dosage: 10 Mg Po Bid. During the same period patient was treated with ETHYOL (View Ethyol Review and Ethyol Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ), TORADOL (View Toradol Review and Toradol Label ). Patient was hospitalized.

4738147-2 | Abdominal Pain, Decreased Appetite, Epigastric Discomfort, Facial Wasting, Lobar Pneumonia, Nausea, Pleural Effusion
Adverse event was reported on Aug 05, 2005 by a Male patient taking Oxandrin (View Usage) (Dosage: 10 Mg Bid X 12 Weeks) was diagnosed with weight control (What is weight control?) and. Location: UNITED STATES , 67 years of age, weighting 162.5 lb, After Oxandrin was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), decreased appetite, epigastric discomfort, facial wasting, lobar pneumonia, nausea (What is nausea?), pleural effusion. Patient was hospitalized.

4727054-7 | Dehydration, Pain, Pancreatic Carcinoma
on Jul 26, 2005 Male patient from UNITED STATES , weighting 140.0 lb, was diagnosed with weight decreased and was treated with Oxandrin (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration, pain (What is pain?), pancreatic carcinoma. Oxandrin dosage: 10 Mg Po Bid. During the same period patient was treated with GEMZAR (View Gemzar Review and Gemzar Label ), TARCEVA (View Tarceva Review and Tarceva Label ), LEUCOVORIN (View Leucovorin Review and Leucovorin Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ).

4727053-5 | Dehydration, Pain, Pancreatic Carcinoma, White Blood Cell Count Increased
on Jul 26, 2005 Male patient from UNITED STATES , weighting 140.0 lb, was diagnosed with weight decreased and was treated with Oxandrin (View Usage). Patient had the following side effects: dehydration, pain (What is pain?), pancreatic carcinoma, white blood cell count increased. Oxandrin dosage: Po Bid. During the same period patient was treated with GEMZAR (View Gemzar Review and Gemzar Label ), TARCEVA (View Tarceva Review and Tarceva Label ), LEUCOVORIN (View Leucovorin Review and Leucovorin Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ). Patient was hospitalized.

4665406-4 | Hypotension, Lobar Pneumonia, Sepsis
Patient was taking Oxandrin (View Usage). After Oxandrin was administered, patient had the following side effects: hypotension, lobar pneumonia, sepsis (What is sepsis?) on May 17, 2005 from Additional patient health information: Male patient , 61 years of age, weighting 157.0 lb, was diagnosed with weight decreased and. Oxandrin dosage: 10 Mg One Po Bid. During the same period patient was treated with PHENERGAN (View Phenergan Review and Phenergan Label ), LORTAB (View Lortab Review and Lortab Label ). Patient was hospitalized.

4660317-2 | Hypotension, Lung Cancer Metastatic, Pneumonia, Sepsis
Adverse event was reported on May 11, 2005 by a Male patient taking Oxandrin (View Usage) (Dosage: 10mg One Po Bid) was diagnosed with weight control (What is weight control?) and. Location: , 61 years of age, weighting 157.0 lb, Patient experienced the following unwanted or unexpected effects: hypotension, lung cancer metastatic, pneumonia (What is pneumonia?), sepsis (What is sepsis?). During the same period patient was treated with PHENERGAN (View Phenergan Review and Phenergan Label ), LORTAB (View Lortab Review and Lortab Label ). Patient was hospitalized.

4591683-4 | Anorexia, Asthenia, Decreased Appetite, Dehydration, Dyspnoea, Fatigue
on Feb 23, 2005 Female patient from , weighting 114.0 lb, was diagnosed with weight decreased and was treated with Oxandrin (View Usage). Patient had the following side effects: anorexia, asthenia, decreased appetite, dehydration, dyspnoea, fatigue. Oxandrin dosage: 100 Mg Po Bid. During the same period patient was treated with TARCEVA (View Tarceva Review and Tarceva Label ). Patient was hospitalized.

4551414-0 | Anorexia, Asthenia, Dehydration, Dyspnoea, Fatigue
on Jan 11, 2005 Female patient from , weighting 114.0 lb, was diagnosed with weight decreased and was treated with Oxandrin (View Usage). After Oxandrin was administered, patient had the following side effects: anorexia, asthenia, dehydration, dyspnoea, fatigue. Oxandrin dosage: 100 Mg Po Bid. During the same period patient was treated with TARCEVA (View Tarceva Review and Tarceva Label ). Patient was hospitalized.